Business
Organigram Announces Results of 2018 Annual & Special Meeting
Organigram Announces Results of 2018 Annual & Special Meeting Organigram Annou...
About this update from Organigram Global Inc.
[{"type":"text","content":"\n\n\n\nOrganigram Announces Results of 2018 Annual & Special Meeting\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nOrganigram Announces Results of 2018 Annual & Special Meeting\nCanada NewsWire\nMONCTON, NB, Dec. 19, 2018\n\n\n\nMONCTON, NB, Dec. 19, 2018 /CNW/ - Organigram Holdings Inc. (TSX VENTURE:OGI) (OTCQB:OGRMF) (the \"Company\" or \"Organigram\"), a leading licensed producer of cannabis based in Moncton, New Brunswick, announces the results of its 2018 Annual and Special Meeting of Shareholders (the \"Meeting\") adjourned from Friday December 7, 2018 and reconvened on Monday, December 17, 2018 in Toronto. \n\n \n \n\n \nShareholders voted to elect all seven of management's nominees to the Board of Directors of the Company, being returning directors Peter Amirault, Derrick West, Michel Bourque, Dr. Kenneth Mitton and Greg Engel, as well as new management nominees Dexter John and Sherry Porter.  All directors are \"independent\" as defined under securities laws, excepting Greg Engel who is also the Chief Executive Officer of the Company. \n\"We are delighted to welcome Sherry and Dexter to our team, each of whom has extensive corporate governance and board experience\", said Greg Engel, Organigram's Chief Executive Officer. \"The addition of these directors complements our Board's skills and experiences, and we are confident they will provide valuable perspectives as we continue to grow in a dynamic industry.\"\nShareholders also approved the following matters:\nRe-appointment of Deloitte LLP as the auditors for the Company for the ensuing year; The continuation of the Company's 10% \"rolling\" share option plan; and The continuation of the Company's equity incentive plan. All matters passed with an approval rate in excess of 90% of shares voted.  The Company's equity incentive plan was approved by ordinary resolution of disinterested shareholders.\nSubsequent to the Meeting, the newly-elected board of directors of Organigram (the \"Board\") re-appointed Peter Amirault as Chairman of the Board.  \nThe Board also re-appointed Derrick West a...